Mangosteen Extract's Potential to Treat Schizophrenia: a randomised controlled trial

Laupu, Wendy (2016) Mangosteen Extract's Potential to Treat Schizophrenia: a randomised controlled trial. Lambert Academic Publishing.

PDF (Front pages) - Supplemental Material
Download (168kB) | Preview
View at Publisher Website:


Many people have received sub-optimal treatment for their schizophrenia or affective disorder. Despite a large monetary investment, over a prolonged period, pharmaceutical companies have failed to deliver novel therapies to the market place. Based on anecdotal testimony and with strong literary support, a pilot study was undertaken. For the randomized controlled trial, 80 participants self-administered either mangosteen pericarp or placebo capsules over an 180 day period. No biomarker has been widely recognized for schizophrenia, so widely accepted measures of outcome were accessed by structured interviews. This book reported if supplementary capsules of mangosteen extract (pericarp), modified symptoms for the treatment of schizophrenia and affective disorders.

Item ID: 44747
Item Type: Book (Scholarly Work)
ISBN: 978-3-659-83540-7
Keywords: antioxidant, neurobiology, schizophrenia, affective disorders, mangosteen extract
Date Deposited: 11 May 2017 04:27
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110319 Psychiatry (incl Psychotherapy) @ 50%
11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111714 Mental Health @ 50%
SEO Codes: 92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920410 Mental Health @ 100%
Downloads: Total: 290
Last 12 Months: 10
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page